Endpoints News quoted Immigration Practice Chair John Quill in an article on the Trump administration’s proposal to require a $100,000 payment for new H-1B visa petitions. The article highlights potential implications for the biotech sector, noting that the change could make it more difficult for companies to recruit international workers with specialized technical skills, which may affect scientific innovation.

In the biotech industry, “it’s just been a struggle to compete with other companies to find qualified talent in the space,” John says. “This is just going to squeeze the market even further.”

Source

Endpoints News